Skip to main content
Erschienen in: Updates in Surgery 2/2022

17.01.2022 | Original Article

Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach

verfasst von: Fabio Carbone, Yinshan Chee, Shahnawaz Rasheed, David Cunningham, Ricky Harminder Bhogal, Long Jiao, Paris Tekkis, Christos Kontovounisios

Erschienen in: Updates in Surgery | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

There is no clear consensus about the best surgical strategy for patients with colorectal cancer (CRC) and synchronous liver metastases (SCRLM).

Methods

Between 2009 and 2019, patients with CRC and SCRLM considered for curative treatment were included. Perioperative and follow-up data were analysed to examine the safety and survival outcomes of primary first (PF), liver first (LF) and simultaneous resection (SR) strategies.

Results

204 patients were identified, consisting of PF (n = 129), LF (n = 26) and SR (n = 49). Forty-five patients (22.1%) failed to have either the primary or the liver metastases resected following initial LF (n = 11, 42.3%) or PF (n = 34, 26.4%), respectively (p < 0.001). The postoperative morbidity rates were 31.0%, 38.4% and 40.8% in PF, LF and SR group, respectively (p = 0.409); the mortality rates were 2.3%, 0% and 4.1%, respectively (p = 0.547). The 1-, 3- and 5-year overall survival (OS) were 94%, 72%, 53% in the PF group, 74%, 54%, 36% in the LF group, and 91%, 74%, 63% in the SR group. LF group had the worst OS compared to PF and SR (p = 0.040, p = 0.052). The 1-, 3- and 5-year disease-free survival (DFS) were 31%, 15%, 10% in PF, 21%, 9% and 9% in LF and 45%, 28% and 28% in SR group, respectively. SR group had a better DFS compared to PF and LF (p = 0.005, p = 0.008). At the multivariate analysis, there was no difference between the three strategies in terms of OS (PF vs SR OS-HR 1.090, p = 0.808; LF vs SR OS-HR 1.582, p = 0.365) and the PF had a worse DFS compared to the SR approach (PF vs SR DFS-HR 1.803, p = 0.007; LF vs SR DFS-HR 1.252, p = 0.492).

Conclusions

PF, LF and SR had comparable postoperative morbidity and mortality. The three surgical strategies had similar OS outcomes. The PF strategy was associated with a worse DFS than SR, while the LF approach was associated with a high failure rate to progress to the second stage (primary tumour resection).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Adam R, de Gramont A, Figueras J et al (2015) Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41(9):729–741CrossRef Adam R, de Gramont A, Figueras J et al (2015) Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41(9):729–741CrossRef
2.
Zurück zum Zitat van der Pool AE, Damhuis RA, Ijzermans JN et al (2012) Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 14(1):56–61CrossRef van der Pool AE, Damhuis RA, Ijzermans JN et al (2012) Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 14(1):56–61CrossRef
3.
Zurück zum Zitat Chow FC, Chok KS (2019) Colorectal liver metastases: an update on multidisciplinary approach. World J Hepatol 11(2):150–172CrossRef Chow FC, Chok KS (2019) Colorectal liver metastases: an update on multidisciplinary approach. World J Hepatol 11(2):150–172CrossRef
4.
Zurück zum Zitat Wanis KN, Pineda-Solis K, Tun-Abraham ME et al (2017) Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review. Hepatobiliary Surg Nutr 6(3):162–169CrossRef Wanis KN, Pineda-Solis K, Tun-Abraham ME et al (2017) Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review. Hepatobiliary Surg Nutr 6(3):162–169CrossRef
5.
Zurück zum Zitat Weledji EP (2017) Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer. Oncol Rev 11(2):331PubMedPubMedCentral Weledji EP (2017) Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer. Oncol Rev 11(2):331PubMedPubMedCentral
6.
Zurück zum Zitat Collins D, Chua H (2017) Contemporary surgical management of synchronous colorectal liver metastases. F1000Res 6:598CrossRef Collins D, Chua H (2017) Contemporary surgical management of synchronous colorectal liver metastases. F1000Res 6:598CrossRef
7.
Zurück zum Zitat von Elm E, Altman DG, Egger M et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499CrossRef von Elm E, Altman DG, Egger M et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499CrossRef
8.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef
9.
Zurück zum Zitat Agarwal GG (2012) Statistics for surgeons—understanding survival analysis. Indian J Surg Oncol 3(3):208–214CrossRef Agarwal GG (2012) Statistics for surgeons—understanding survival analysis. Indian J Surg Oncol 3(3):208–214CrossRef
10.
Zurück zum Zitat de Haas RJ, Adam R, Wicherts DA et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 97(8):1279–1289CrossRef de Haas RJ, Adam R, Wicherts DA et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 97(8):1279–1289CrossRef
11.
Zurück zum Zitat Slesser AAP, Chand M, Goldin R, Brown G, Tekkis PP, Mudan S (2013) Outcomes of simultaneous resections for patients with synchronous colorectal liver metastases. Eur J Surg Oncol 39(12):1384–1393CrossRef Slesser AAP, Chand M, Goldin R, Brown G, Tekkis PP, Mudan S (2013) Outcomes of simultaneous resections for patients with synchronous colorectal liver metastases. Eur J Surg Oncol 39(12):1384–1393CrossRef
12.
Zurück zum Zitat Bogach J, Wang J, Griffiths C et al (2020) Simultaneous versus staged resection for synchronous colorectal liver metastases: a population-based cohort study. Int J Surg 74:68–75CrossRef Bogach J, Wang J, Griffiths C et al (2020) Simultaneous versus staged resection for synchronous colorectal liver metastases: a population-based cohort study. Int J Surg 74:68–75CrossRef
13.
Zurück zum Zitat Nitsche U, Weber C, Kaufmann B et al (2020) Simultaneous versus staged resection of colorectal cancer liver metastasis: a retrospective single-center study. J Surg Res 255:346–354CrossRef Nitsche U, Weber C, Kaufmann B et al (2020) Simultaneous versus staged resection of colorectal cancer liver metastasis: a retrospective single-center study. J Surg Res 255:346–354CrossRef
14.
Zurück zum Zitat Valdimarsson VT, Syk I, Lindell G et al (2020) Outcomes of simultaneous resections and classical strategy for synchronous colorectal liver metastases in Sweden: a nationwide study with special reference to major liver resections. World J Surg 44(7):2409–2417CrossRef Valdimarsson VT, Syk I, Lindell G et al (2020) Outcomes of simultaneous resections and classical strategy for synchronous colorectal liver metastases in Sweden: a nationwide study with special reference to major liver resections. World J Surg 44(7):2409–2417CrossRef
15.
Zurück zum Zitat Wang LJ, Wang HW, Jin KM, Li J, Xing BC (2020) Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases. BMC Surg 20(16):1–9 Wang LJ, Wang HW, Jin KM, Li J, Xing BC (2020) Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases. BMC Surg 20(16):1–9
16.
Zurück zum Zitat Thelen A, Jonas S, Benckert C et al (2007) Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 22(10):1269–1276CrossRef Thelen A, Jonas S, Benckert C et al (2007) Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 22(10):1269–1276CrossRef
17.
Zurück zum Zitat Martin RC, Augenstein V, Reuter NP, Scoggins CR, McMasters KM (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208(5):842–850CrossRef Martin RC, Augenstein V, Reuter NP, Scoggins CR, McMasters KM (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208(5):842–850CrossRef
18.
Zurück zum Zitat Boudjema K, Locher C, Sabbagh C et al (2021) Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial. Ann Surg 273(1):49–56CrossRef Boudjema K, Locher C, Sabbagh C et al (2021) Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial. Ann Surg 273(1):49–56CrossRef
19.
Zurück zum Zitat Giuliante F, Viganò L, De Rose AM et al (2021) Liver-first approach for synchronous colorectal metastases: analysis of 7360 patients from the LiverMetSurvey registry. Ann Surg Oncol 28(13):8198–8208CrossRef Giuliante F, Viganò L, De Rose AM et al (2021) Liver-first approach for synchronous colorectal metastases: analysis of 7360 patients from the LiverMetSurvey registry. Ann Surg Oncol 28(13):8198–8208CrossRef
20.
Zurück zum Zitat Roberts KJ, White A, Cockbain A et al (2014) Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg 101(7):856–866CrossRef Roberts KJ, White A, Cockbain A et al (2014) Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg 101(7):856–866CrossRef
21.
Zurück zum Zitat Kumar R, Dennison AR, Robertson V, Jones MJ, Neal CP, Garcea G (2018) Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases. ANZ J Surg 88(1–2):E16–E20CrossRef Kumar R, Dennison AR, Robertson V, Jones MJ, Neal CP, Garcea G (2018) Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases. ANZ J Surg 88(1–2):E16–E20CrossRef
22.
Zurück zum Zitat Labori KJ, Guren MG, Brudvik KW et al (2017) Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal Dis 19(8):731–738CrossRef Labori KJ, Guren MG, Brudvik KW et al (2017) Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal Dis 19(8):731–738CrossRef
23.
Zurück zum Zitat Gall TM, Basyouny M, Frampton AE et al (2014) Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases. Colorectal Dis 16(6):O197-205CrossRef Gall TM, Basyouny M, Frampton AE et al (2014) Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases. Colorectal Dis 16(6):O197-205CrossRef
24.
Zurück zum Zitat Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197(2):233–241CrossRef Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197(2):233–241CrossRef
25.
Zurück zum Zitat Le Souder E, Azin A, Wood T et al (2018) The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy. J Surg Oncol 118(1):86–94CrossRef Le Souder E, Azin A, Wood T et al (2018) The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy. J Surg Oncol 118(1):86–94CrossRef
26.
Zurück zum Zitat Silberhumer GR, Paty PB, Temple LK et al (2015) Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 209(6):935–942CrossRef Silberhumer GR, Paty PB, Temple LK et al (2015) Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 209(6):935–942CrossRef
27.
Zurück zum Zitat Gavriilidis P, Katsanos K, Sutcliffe RP, Simopoulos C, Azoulay D, Roberts KJ (2019) Simultaneous, delayed and liver-first hepatic resections for synchronous colorectal liver metastases: a systematic review and network meta-analysis. J Clin Med Res 11(8):572–582CrossRef Gavriilidis P, Katsanos K, Sutcliffe RP, Simopoulos C, Azoulay D, Roberts KJ (2019) Simultaneous, delayed and liver-first hepatic resections for synchronous colorectal liver metastases: a systematic review and network meta-analysis. J Clin Med Res 11(8):572–582CrossRef
28.
Zurück zum Zitat She WH, Chan AC, Poon RT et al (2015) Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection? ANZ J Surg 85(11):829–833CrossRef She WH, Chan AC, Poon RT et al (2015) Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection? ANZ J Surg 85(11):829–833CrossRef
Metadaten
Titel
Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach
verfasst von
Fabio Carbone
Yinshan Chee
Shahnawaz Rasheed
David Cunningham
Ricky Harminder Bhogal
Long Jiao
Paris Tekkis
Christos Kontovounisios
Publikationsdatum
17.01.2022
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 2/2022
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-021-01234-w

Weitere Artikel der Ausgabe 2/2022

Updates in Surgery 2/2022 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.